BioSpace News Archive

INOVIO, a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, reported financial results for the quarter ended June 30, 2021.

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, announced its financial results for the second quarter of 2021 and provided a corporate update.

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, and Helio Health (“Helio”), an AI-biotechnology company developing blood-based early cancer detection tests, today announced the companies have entered into a strategic partnership to commercialize Helio’s blood-based early cancer detection tests.

Atara Biotherapeutics, Inc. today reported financial results for the second quarter 2021, recent business highlights and key catalysts over the next several months.

Amphastar Pharmaceuticals, Inc. today reported results for the three months ended June 30, 2021.

Celcuity today announced financial results for the second quarter ended June 30, 2021 and summarized recent business progress.

Medexus Pharmaceuticals Inc. announced that it will be presenting at the Canaccord Genuity 41st Annual Growth Conference being held virtually from August 10th to 12th, 2021.

Kaleido Biosciences, Inc. today announced the appointment of current Board member Theo Melas-Kyriazi as Chairperson of the Board of Directors effective August 9, 2021.

Aethlon Medical, Inc., a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, reported financial results for its first quarter ended June 30, 2021 and provided an update on recent developments.

Catabasis Pharmaceuticals, Inc. today reported financial results for the second quarter ended June 30, 2021 and provided a corporate update.